.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
US Army
Mallinckrodt
Daiichi Sankyo
Novartis
Cipla
Citi
Medtronic
QuintilesIMS
AstraZeneca

Generated: June 29, 2017

DrugPatentWatch Database Preview

Fosinopril sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fosinopril sodium and what is the scope of fosinopril sodium patent protection?

Fosinopril sodium
is the generic ingredient in four branded drugs marketed by Apotex Inc, Bristol Myers Squibb, Actavis Labs Fl Inc, Invagen Pharms, Watson Labs, Teva, Aurobindo Pharma Ltd, Prinston Inc, Ranbaxy Labs Ltd, Upsher-smith Labs, Mylan, Emcure Pharms India, Sun Pharm Inds Ltd, Aurobindo Pharma, and Sandoz, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for fosinopril sodium. Sixteen suppliers are listed for this compound.

Summary for Generic Name: fosinopril sodium

Tradenames:4
Patents:1
Applicants:15
NDAs:22
Drug Master File Entries: see list6
Suppliers / Packagers: see list16
Bulk Api Vendors: see list57
Clinical Trials: see list2,350
Patent Applications: see list1,311
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fosinopril sodium at DailyMed

Pharmacology for Ingredient: fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL091163-002Mar 30, 2011ABRXNoNo► Subscribe► Subscribe
Upsher-smith Labs
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076188-001Oct 8, 2004DISCNNoNo► Subscribe► Subscribe
Upsher-smith Labs
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL076483-003Apr 23, 2004ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
FOSINOPRIL SODIUM
fosinopril sodium
TABLET;ORAL091163-003Mar 30, 2011ABRXNoNo► Subscribe► Subscribe
Teva
FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
fosinopril sodium; hydrochlorothiazide
TABLET;ORAL076945-002Jul 5, 2006DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: fosinopril sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-003May 16, 19914,337,201*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-003May 16, 19915,006,344*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-002May 16, 19914,337,201*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-002May 16, 19915,006,344*PED► Subscribe
Bristol Myers Squibb
MONOPRIL
fosinopril sodium
TABLET;ORAL019915-004Mar 28, 19954,337,201*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Colorcon
Merck
Federal Trade Commission
Mallinckrodt
McKesson
Chubb
McKinsey
Covington
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot